Euro Diagnostica AB announces new distribution agreement with the Binding Site Group Ltd.

June 1, 2016 - Company News
Euro Diagnostica AB (Euro Diagnostica) is pleased to announce an agreement with Binding Site’s Immunologicals Group of Birmingham, UK, for distribution of a range of Autoimmune Antigens and Monoclonal Antibodies through the Binding Site Immunologicals Group.

The agreement will further increase the distribution of a range of Euro Diagnostica Autoimmune Antigens and Monoclonal Antibodies through the Binding Site Immunologicals Group sales channels and enable more effective support for current and future customers.

Binding Site’s Immunologicals Group serves the in-vitro diagnostic (IVD) manufacturing and life-science research markets with a comprehensive line of innovative products.

The range of native antigens available from Euro-Diagnostica includes the flagship GBM material. “Entering into a strategic Autoimmune Antigens and Antibodies distribution partnership with the Binding Site is an important opportunity for Euro Diagnostica to ensure continuous focus on our important high quality products, and together with the Binding Site team members globally, we can now reach more customers.” says Else Beth Trautner, CEO at Euro Diagnostica.

“We are delighted to be working with Euro Diagnostica to extend their product reach globally” added Binding Site’s Immunologicals Global Business Manager Julia Nisbet-Fahy. ”Our experience in supplying our own special protein material to a wide range of clients is well placed to support our expected growth”.

Binding Site’s Immunologicals Group provides special protein materials including antibodies, antigens, disease state sera and blockers to manufacturers and researchers globally.

Click to view the full press release

« Back